Delivery Order SPE2DB25D3404-SPE2DB25FUMYB

Award Date 4/14/25
Potential Completion Date 4/15/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567327877 PROVISC 10 MG/ML DISP SYRNG 0.55ML, a medical product, with a ceiling value of $1,466.32. The contract is a firm fixed price Delivery Order, with a period of performance through February 21, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 4566997519 PROVISC 10 MG/ML DISP SYRNG 0.55ML, with a ceiling value of $6,571.28 and a period of performance running through January 22, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,443.66, is for the procurement of 4566988475 ! PROVISC 10 MG/ML DISP SYRNG 0.85ML medical supplies. The contract has a firm fixed price and an ultimate completion date of January 22, 2025. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567599261 PROVISC 10 MG/ML DISP SYRNG 0.55ML medical supplies. The contract has a ceiling value of $1,906.20 and is a firm fixed price delivery order. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a $2,749.35 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of PROVISC 10 MG/ML DISP SYRNG 0.55ML, a medical product, to support federal healthcare programs. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $3,299.58 firm fixed-price delivery order is for the provision of 4564354498 ! PROVISC 10 MG/ML DISP SYRNG 0.55ML, a pharmaceutical product. The contract has an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Provisc 10 mg/ml disposable syringes, 0.85 ml, with a ceiling value of $1,319.81. It is a firm fixed-price contract with an ultimate completion date of April 15, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4566054025 PROVISC 10 MG/ML DISP SYRNG 0.55ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $1,605.60 and an ultimate completion date of October 9, 2024. This contract is not set aside for any specific business category. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,542.27 Firm Fixed Price Delivery Order is for the procurement of 4566760134 - PROVISC 10 MG/ML DISP SYRNG 0.55ML, with a completion date of December 19, 2024. The award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, to provide a wide range of medical supplies and prescription drugs. The contract, valued at up to $2,749.65, is for the delivery of 4565617560 ! PROVISC 10 MG/ML DISP SYRNG 0.55ML to support military treatment facilities and healthcare programs. This delivery order contract has a firm fixed price pricing structure and an...
  • SPE2DB25D3404
    Indefinite Delivery Contract
  • SPE2DB25D3404-SPE2DB25FUMYB
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4567906557 - PROVISC 10 MG/ML DISP SYRNG 0.55ML. The contract has a firm fixed price and a ceiling value of $1,906.20. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/14/25, 10:43 AM